Anthem Biosciences Settles INR 1,276.83 Million Upside Sharing Arrangement
Anthem Biosciences Ltd 路 Others (Uncategorized) 路 09 Sept 2026, 3:44 am
Anthem Biosciences Settles INR 1,276.83 Million Upside Sharing Arrangement Anthem Biosciences has executed the settlement of an upside sharing arrangement amounting to approximately INR 1,276.83 million. The payout, arising from the divestment by Viridity Tone LLP, has been settled with Upside Principal Shareholders鈥擬r. Ajay Bhardwaj, Mr. Ganesh Sambasivam, and Mr. K. Ravindra Chandrappa. The transaction was implemented pursuant to the Waiver-cum-Amendment Agreement dated 30th Dec'24 under Regulation 26(6) of SEBI LODR Regulations, following shareholder approval secured at the AGM held on 22nd Jul'26.
Original exchange filing (PDF)
More announcements from Anthem Biosciences Ltd
- Transcript of Q2 & H1 FY27 Earnings Conference Call 路 06 Nov 2026
- Audio recording of Earnings Call for the quarter ended September 30, 2026. 路 05 Nov 2026
- Intimation of Schedule of Analyst Meet/Institutional Meet 路 05 Nov 2026
- Investors presentation for the financial results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Press release for the financial results for the quarter and half year ended September 30, 2026 路 03 Nov 2026
- Submission of the outcome of the Board Meeting held on November 03, 2026, for approval of the Unaudited Financial results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Submission of outcome of the Board Meeting approving the Unaudited Financial results for the quarter and half year ended September 30, 2026, on November 03, 2026 路 03 Nov 2026
- Anthem Biosciences Limited has submitted to the Exchange, the unaudited standalone and consolidated financial results for the period ended September 30, 2026. 路 03 Nov 2026
